Evaluation of Diabetes Care at Austrian GPs (DCA09)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00979394
Recruitment Status : Terminated
First Posted : September 18, 2009
Last Update Posted : August 17, 2010
Bristol-Myers Squibb
Information provided by:

Brief Summary:

This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:

  • To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,
  • To evaluate representative profile of patient with T2D in Austria,
  • To evaluate which medical therapies are used.

Condition or disease
Type 2 Diabetes

Study Type : Observational
Actual Enrollment : 1513 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diabetes Care Austria 2009
Study Start Date : October 2009
Actual Primary Completion Date : January 2010
Actual Study Completion Date : January 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Patients with type 2 diabetes

Primary Outcome Measures :
  1. Evaluate characteristics or co morbidities being existent for patient with T2D at GP [ Time Frame: Once per patient ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Inclusion Criteria:

  • Diabetes mellitus type II

Exclusion Criteria:

  • Diabetes mellitus type I
  • Gestation diabetes
  • Induced diabetes

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00979394

Sponsors and Collaborators
Bristol-Myers Squibb
Study Chair: Bernhard Ludvig General Hospital Vienna
Study Chair: Guntram Schernthaner Krankenanstalt Rudolfsstiftung

Responsible Party: MC MD, AstraZeneca Identifier: NCT00979394     History of Changes
Other Study ID Numbers: NIS-CAT-DUM-2009/1
First Posted: September 18, 2009    Key Record Dates
Last Update Posted: August 17, 2010
Last Verified: August 2010

Keywords provided by AstraZeneca:
Diabetes Care at GPs in Austria
Characteristic of diabetes patients at GPs in Austria

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases